TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noae019 ↗Kurz gefasst
Editorial in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Sourav Ghosh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Brain Neoplasms, Receptors, Immunologic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In the Mahabharata, the rival Durjyadhona gets embarrassed visiting Yudhishthira’s remarkable Indraprastha palace. He mistakenly tried to keep his clothes from becoming wet on shimmering marble floors that looked like pools. Next, Durjyadhona fell into a crystal-clear pool that looked like a floor engraved with lotus designs. Trying to leave the palace, he bumped into closed mirrored doors reflecting verdant gardens while passing by openings that appeared walled off. A series of recent findings on Triggering Receptor Expressed on Myeloid cells 2 (TREM2) in glioblastoma can be equally stunning and confusing for the readers—a study by Sun et al. describes that TREM2 loss of function or inhibition improved outcome in mouse models of glioblastoma,1 yet independent studies by Zheng et al. and Peshoff et al. did not observe a beneficial outcome.2,3 While Sun et al. describe an innate- and a CD8+ T-cell-driven effect in limiting glioblastoma growth, Zheng et al. and Peshoff et al. find CD4+ T cells as effectors. With TREM2 emerging as an outstanding edifice in the kingdom of immuno-oncology and neuroimmunology, can we uncover the cues that can help us navigate the real from the illusory? Comparing aspects of the studies by Sun et al., Zheng et al. and Peshoff et al. are fraught with challenges of sample heterogeneity and approach nonuniformity. Additionally, activation of T cells in the brain is more difficult to understand compared to that in peripheral tissues. One clear difference between the studies, however, is in the glioblastoma lines used for implantation in Trem2 –/– mice. The following are a few variables to consider:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Sourav Ghosh
Zitieren
APA
Ghosh, S., & Rothlin, C. V. (2024). TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae019
Vancouver
Ghosh S, Rothlin CV. TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae019
BibTeX
@article{Ghosh2024,
author = {Ghosh, Sourav and Rothlin, Carla V},
title = {TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noae019}
}
EUVIMED